formation
发表于 2025-3-21 17:47:27
书目名称Clostridioides difficile影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0228383<br><br> <br><br>书目名称Clostridioides difficile读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0228383<br><br> <br><br>
evince
发表于 2025-3-21 22:08:32
http://reply.papertrans.cn/23/2284/228383/228383_2.png
结束
发表于 2025-3-22 04:25:44
https://doi.org/10.1007/978-3-662-02617-5e and vancomycin are still the antibiotics of choice for treating CDI; however, the first . strains with a reduced susceptibility against these antibiotics have been encountered. Supporting the colonization resistance associated with a diverse and balanced gut microbiota is most likely the best prot
mastoid-bone
发表于 2025-3-22 08:04:03
Book 2021 difficile. helps the reader gain a better understanding of C. difficile, the challenges that may arise and the available treatment options. Given its broad coverage and features, it will appeal to a wide readership, from gastroenterologists through general physicians, nurses, and other healthcare p
entice
发表于 2025-3-22 09:05:06
Epidemiology,on which inactivated a negative regulator of the toxin production (tcdC) in the pathogenicity locus. Over the last years a large number of different ribotypes of . have been identified by international surveillance programs. Recurrence of CDI is occurring in 10–25% of patients after a primary infect
construct
发表于 2025-3-22 14:51:26
Treatment of CDI,a has been claimed to provide the best protection against CDI, resulting in the suggestion to support the gut microbiota with products containing probiotic bacteria (probiotics or synbiotics). Despite positive reports, clinical evidence is still slim to support a recommendation of these products for
construct
发表于 2025-3-22 17:24:07
Summary and Discussion,e and vancomycin are still the antibiotics of choice for treating CDI; however, the first . strains with a reduced susceptibility against these antibiotics have been encountered. Supporting the colonization resistance associated with a diverse and balanced gut microbiota is most likely the best prot
大都市
发表于 2025-3-22 23:48:33
http://reply.papertrans.cn/23/2284/228383/228383_8.png
Mindfulness
发表于 2025-3-23 01:54:25
Diagnosis of CDI,on of the .-specific glutamate dehydrogenase (GDH) and toxins (TcdA and/or TcdB) in feces using enzyme immune assays (EIAs). Nucleic acid amplification tests (NAAT) are used to detect .-specific genes (16 rRNA, GDH) and the toxin genes (tcdA and tcdB). Diagnosis of CDI is employing either a two-step or a three-step algorithm.
Accolade
发表于 2025-3-23 05:59:43
https://doi.org/10.1007/978-3-642-88138-1on of the .-specific glutamate dehydrogenase (GDH) and toxins (TcdA and/or TcdB) in feces using enzyme immune assays (EIAs). Nucleic acid amplification tests (NAAT) are used to detect .-specific genes (16 rRNA, GDH) and the toxin genes (tcdA and tcdB). Diagnosis of CDI is employing either a two-step or a three-step algorithm.